Submitted by: Submitted by wamy156
Views: 10
Words: 780
Pages: 4
Category: Business and Industry
Date Submitted: 07/28/2016 07:43 AM
Pharmacovigilance Market will Grow at a CAGR of 13% by 2020 by Market Research Engine
New York, July 26: Market Research Engine has published a new report titled as
“Pharmacovigilance Market (Phases of Drug Development: Preclinical Studies,
Clinical Trial Phase I, II, III & IV or Post Marketing Surveillance; Type of Methods:
Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous
Reporting, Cohort Event Monitoring, & EHR Mining; Type of Service: In-House &
Contract Outsourcing) - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2014 - 2020”
Pharmacovigilance is associated with drug safety which involves gathering, detecting,
monitoring and preventing adverse reaction of drug. It mainly focuses on adverse drug
reactions. The information accumulated from healthcare providers and patients plays a
significant role in pharmacovigilance to transpire. The whole purpose of pharmacovigilance
is to minimize the adverse effects of drugs on the patients.
Browse Full Report:
https://www.marketresearchengine.com/reportdetails/pharmacovigilance-market
Global pharmacovigilance market was valued USD 2.5 billion in 2014. The revenue of this
market is projected to increase at CAGR of 13% during the forecast period.North America is
the leading market for pharmacovigilance market globally with largest market 2014. Europe
is a subsequent market owing to implementation of pharmacovigilance. Asia Pacific market
is fastest growing market with highest CAGR accounted in 2014.
Increasing need of pharmacovigilance owing to increasing prevalence of adverse drug
reaction is a major driving factor.Rise in intricacy of drug safety regulation by government is
a growth factor for this market. Growing demand in paints & coating industry is one of the
driving factor.
The global pharmacovigilance market according to clinical trial phase is segmented aspreclinical, Phase I, Phase II, Phase IIIandPhase IV. The type of service provider segment...